116 related articles for article (PubMed ID: 1322432)
1. Expression of type I, but not type II insulin-like growth factor receptor on both undifferentiated and differentiated HT29 human colon carcinoma cell line.
Remacle-Bonnet MM; Culouscou JM; Garrouste FL; Rabenandrasana C; Marvaldi JL; Pommier GJ
J Clin Endocrinol Metab; 1992 Aug; 75(2):609-16. PubMed ID: 1322432
[TBL] [Abstract][Full Text] [Related]
2. Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells.
Rosenfeld RG; Ceda G; Cutler CW; Dollar LA; Hoffman AR
Endocrinology; 1985 Nov; 117(5):2008-16. PubMed ID: 2995005
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells.
Garrouste FL; Remacle-Bonnet MM; Lehmann MM; Marvaldi JL; Pommier GJ
Endocrinology; 1997 May; 138(5):2021-32. PubMed ID: 9112401
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
[TBL] [Abstract][Full Text] [Related]
5. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites.
Casella SJ; Han VK; D'Ercole AJ; Svoboda ME; Van Wyk JJ
J Biol Chem; 1986 Jul; 261(20):9268-73. PubMed ID: 3013881
[TBL] [Abstract][Full Text] [Related]
7. Characterization of type I and type II insulin-like growth factor receptors in an intestinal epithelial cell line.
Park JH; Vanderhoof JA; Blackwood D; Macdonald RG
Endocrinology; 1990 Jun; 126(6):2998-3005. PubMed ID: 2161743
[TBL] [Abstract][Full Text] [Related]
8. Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: an in-vitro model.
Thompson MA; Cox AJ; Whitehead RH; Jonas HA
Endocrinology; 1990 Jun; 126(6):3033-42. PubMed ID: 1693565
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs).
McCusker RH; Camacho-Hubner C; Bayne ML; Cascieri MA; Clemmons DR
J Cell Physiol; 1990 Aug; 144(2):244-53. PubMed ID: 2166057
[TBL] [Abstract][Full Text] [Related]
10. Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone.
Centrella M; McCarthy TL; Canalis E
Endocrinology; 1990 Jan; 126(1):39-44. PubMed ID: 2152868
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I receptors in normal and neoplastic human endometrium.
Talavera F; Reynolds RK; Roberts JA; Menon KM
Cancer Res; 1990 May; 50(10):3019-24. PubMed ID: 2159368
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor receptors and binding protein in rat neuroblastoma cells.
Sturm MA; Conover CA; Pham H; Rosenfeld RG
Endocrinology; 1989 Jan; 124(1):388-96. PubMed ID: 2462492
[TBL] [Abstract][Full Text] [Related]
13. Type-II insulin-like growth-factor receptor in conditioned medium from HT-29 human colon carcinoma cell line.
Garrouste F; Remacle-Bonnet M; Culouscou JM; Marvaldi J; Pommier G
Int J Cancer; 1991 Mar; 47(5):760-4. PubMed ID: 1848538
[TBL] [Abstract][Full Text] [Related]
14. Interaction of insulin-like growth factors with a nonfusing mouse muscle cell line: binding, action, and receptor down-regulation.
de Vroede MA; Romanus JA; Standaert ML; Pollet RJ; Nissley SP; Rechler MM
Endocrinology; 1984 May; 114(5):1917-29. PubMed ID: 6325137
[TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated endocytosis and lysosomal processing of insulin-like growth factor I by mitogenically responsive cells.
Furlanetto RW
Endocrinology; 1988 May; 122(5):2044-53. PubMed ID: 2966062
[TBL] [Abstract][Full Text] [Related]
16. des-(1-3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells.
Remacle-Bonnet M; Garrouste F; el Atiq F; Roccabianca M; Marvaldi J; Pommier G
Int J Cancer; 1992 Dec; 52(6):910-7. PubMed ID: 1281142
[TBL] [Abstract][Full Text] [Related]
17. High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.
Milazzo G; Yip CC; Maddux BA; Vigneri R; Goldfine ID
J Clin Invest; 1992 Mar; 89(3):899-908. PubMed ID: 1311720
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor receptors in rat placental membranes.
Pilistine SJ; Moses AC; Munro HN
Endocrinology; 1984 Sep; 115(3):1060-5. PubMed ID: 6086283
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.
Ritvos O; Ranta T; Jalkanen J; Suikkari AM; Voutilainen R; Bohn H; Rutanen EM
Endocrinology; 1988 May; 122(5):2150-7. PubMed ID: 2452077
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic effects of human recombinant insulin on B-cell precursor acute lymphoblastic leukemia cells.
Neely EK; Rosenfeld RG; Illescas A; Smith SD
Leukemia; 1992 Nov; 6(11):1134-42. PubMed ID: 1434795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
